192
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Different particulate systems—bypass the biological barriers?

, &
Pages 243-253 | Received 22 Jul 2009, Accepted 08 Oct 2009, Published online: 02 Nov 2009
 

Abstract

The human body has adapted to defend against the aggressive biological or chemical agents. As a result, the defence mechanisms of the human body became barriers for the drug delivery. Theoretically, any problem that prevents a drug from reaching its site of action is considered to be a barrier to drug delivery. The aim of this article is to discuss the possibility of three types of nanocarriers (nanoparticles, liposomes, and solid lipid nanoparticles) to help the drugs to pass some important biological barriers (blood–brain barriers, skin, eye, and tumors) using different strategies/designs of drug delivery systems.

Acknowledgements

Declaration of interest: The following research grant was received: CNCSIS - PN II - IDEI - 708/2009.

The Early Online version of this article published online ahead of print on 2 November 2009 contained an error in the declaration of interest section. The declaration of interest should read: The following research grant was received: CNCSIS - PN II - IDEI - 708/2009. The corrected version will feature in issue GDRT 18(4).

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 767.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.